Cargando…

Validation of the Swedish Multidimensional Dyspnea Profile (MDP) in outpatients with cardiorespiratory disease

INTRODUCTION: Breathlessness is a cardinal symptom in cardiorespiratory disease. An instrument for measuring different aspects of breathlessness was recently developed, the Multidimensional Dyspnea Profile (MDP). This study aimed to validate the MDP in terms of the underlying factor structure, inter...

Descripción completa

Detalles Bibliográficos
Autores principales: Ekström, Magnus, Bornefalk, Hans, Sköld, Magnus, Janson, Christer, Blomberg, Anders, Sandberg, Jacob, Bornefalk-Hermansson, Anna, Igelström, Helena, Sundh, Josefin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797429/
https://www.ncbi.nlm.nih.gov/pubmed/31681476
http://dx.doi.org/10.1136/bmjresp-2018-000381
_version_ 1783459825799135232
author Ekström, Magnus
Bornefalk, Hans
Sköld, Magnus
Janson, Christer
Blomberg, Anders
Sandberg, Jacob
Bornefalk-Hermansson, Anna
Igelström, Helena
Sundh, Josefin
author_facet Ekström, Magnus
Bornefalk, Hans
Sköld, Magnus
Janson, Christer
Blomberg, Anders
Sandberg, Jacob
Bornefalk-Hermansson, Anna
Igelström, Helena
Sundh, Josefin
author_sort Ekström, Magnus
collection PubMed
description INTRODUCTION: Breathlessness is a cardinal symptom in cardiorespiratory disease. An instrument for measuring different aspects of breathlessness was recently developed, the Multidimensional Dyspnea Profile (MDP). This study aimed to validate the MDP in terms of the underlying factor structure, internal consistency, test–retest reliability and concurrent validity in Swedish outpatients with cardiorespiratory disease. METHODS: Outpatients with stable cardiorespiratory disease and breathlessness in daily life were recruited. Factor structure of MDP was analysed using confirmatory factor analysis; internal consistency was analysed using Cronbach’s alpha; and test–retest reliability was analysed using intraclass correlation coefficients (ICCs) for patients with unchanged breathlessness between assessments (baseline, after 30–90 min and 2 weeks). Concurrent validity was evaluated using correlations with validated scales of breathlessness, anxiety, depression and health-related quality of life. RESULTS: In total, 182 outpatients with cardiorespiratory disease and breathlessness in daily life were included; 53.3% were women; main diagnoses were chronic obstructive pulmonary disease (24.7%), asthma (21.4%), heart failure (19.2%) and idiopathic pulmonary fibrosis (18.7%). The MDP total, immediate perception and emotional response scores, and individual item scores showed expected factor structure and acceptable measurement properties: internal consistency (Cronbach’s alpha, range 0.80–0.93); test–retest reliability at 30–90 min and 2 weeks (ICC, range 0.67–0.91); and concurrent validity. There was no evidence of a learning effect. Findings were similar between diagnoses. DISCUSSION: MDP is a valid instrument for multidimensional measurement of breathlessness in Swedish outpatients across cardiorespiratory diseases.
format Online
Article
Text
id pubmed-6797429
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-67974292019-11-01 Validation of the Swedish Multidimensional Dyspnea Profile (MDP) in outpatients with cardiorespiratory disease Ekström, Magnus Bornefalk, Hans Sköld, Magnus Janson, Christer Blomberg, Anders Sandberg, Jacob Bornefalk-Hermansson, Anna Igelström, Helena Sundh, Josefin BMJ Open Respir Res Respiratory Research INTRODUCTION: Breathlessness is a cardinal symptom in cardiorespiratory disease. An instrument for measuring different aspects of breathlessness was recently developed, the Multidimensional Dyspnea Profile (MDP). This study aimed to validate the MDP in terms of the underlying factor structure, internal consistency, test–retest reliability and concurrent validity in Swedish outpatients with cardiorespiratory disease. METHODS: Outpatients with stable cardiorespiratory disease and breathlessness in daily life were recruited. Factor structure of MDP was analysed using confirmatory factor analysis; internal consistency was analysed using Cronbach’s alpha; and test–retest reliability was analysed using intraclass correlation coefficients (ICCs) for patients with unchanged breathlessness between assessments (baseline, after 30–90 min and 2 weeks). Concurrent validity was evaluated using correlations with validated scales of breathlessness, anxiety, depression and health-related quality of life. RESULTS: In total, 182 outpatients with cardiorespiratory disease and breathlessness in daily life were included; 53.3% were women; main diagnoses were chronic obstructive pulmonary disease (24.7%), asthma (21.4%), heart failure (19.2%) and idiopathic pulmonary fibrosis (18.7%). The MDP total, immediate perception and emotional response scores, and individual item scores showed expected factor structure and acceptable measurement properties: internal consistency (Cronbach’s alpha, range 0.80–0.93); test–retest reliability at 30–90 min and 2 weeks (ICC, range 0.67–0.91); and concurrent validity. There was no evidence of a learning effect. Findings were similar between diagnoses. DISCUSSION: MDP is a valid instrument for multidimensional measurement of breathlessness in Swedish outpatients across cardiorespiratory diseases. BMJ Publishing Group 2019-09-18 /pmc/articles/PMC6797429/ /pubmed/31681476 http://dx.doi.org/10.1136/bmjresp-2018-000381 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Respiratory Research
Ekström, Magnus
Bornefalk, Hans
Sköld, Magnus
Janson, Christer
Blomberg, Anders
Sandberg, Jacob
Bornefalk-Hermansson, Anna
Igelström, Helena
Sundh, Josefin
Validation of the Swedish Multidimensional Dyspnea Profile (MDP) in outpatients with cardiorespiratory disease
title Validation of the Swedish Multidimensional Dyspnea Profile (MDP) in outpatients with cardiorespiratory disease
title_full Validation of the Swedish Multidimensional Dyspnea Profile (MDP) in outpatients with cardiorespiratory disease
title_fullStr Validation of the Swedish Multidimensional Dyspnea Profile (MDP) in outpatients with cardiorespiratory disease
title_full_unstemmed Validation of the Swedish Multidimensional Dyspnea Profile (MDP) in outpatients with cardiorespiratory disease
title_short Validation of the Swedish Multidimensional Dyspnea Profile (MDP) in outpatients with cardiorespiratory disease
title_sort validation of the swedish multidimensional dyspnea profile (mdp) in outpatients with cardiorespiratory disease
topic Respiratory Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797429/
https://www.ncbi.nlm.nih.gov/pubmed/31681476
http://dx.doi.org/10.1136/bmjresp-2018-000381
work_keys_str_mv AT ekstrommagnus validationoftheswedishmultidimensionaldyspneaprofilemdpinoutpatientswithcardiorespiratorydisease
AT bornefalkhans validationoftheswedishmultidimensionaldyspneaprofilemdpinoutpatientswithcardiorespiratorydisease
AT skoldmagnus validationoftheswedishmultidimensionaldyspneaprofilemdpinoutpatientswithcardiorespiratorydisease
AT jansonchrister validationoftheswedishmultidimensionaldyspneaprofilemdpinoutpatientswithcardiorespiratorydisease
AT blomberganders validationoftheswedishmultidimensionaldyspneaprofilemdpinoutpatientswithcardiorespiratorydisease
AT sandbergjacob validationoftheswedishmultidimensionaldyspneaprofilemdpinoutpatientswithcardiorespiratorydisease
AT bornefalkhermanssonanna validationoftheswedishmultidimensionaldyspneaprofilemdpinoutpatientswithcardiorespiratorydisease
AT igelstromhelena validationoftheswedishmultidimensionaldyspneaprofilemdpinoutpatientswithcardiorespiratorydisease
AT sundhjosefin validationoftheswedishmultidimensionaldyspneaprofilemdpinoutpatientswithcardiorespiratorydisease